Breaking News

VitamFero, Sirona Biochem To Test Preservation Technology

MTA aims to enhance storage time for animal vaccines

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Sirona Biochem Corp. has signed a material transfer agreement with VitamFero, a veterinary healthcare company, to test Sirona’s biological preservation technology with the goal of extending the storage time of its live attenuated animal vaccines.   Using its chemistry technology, Sirona Biochem develops biological preservation compounds to extend the life of stem cells, blood platelets, islets cells, tissues, organs and other biologics.   “By developing technology that can preserve b...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters